Phoenix
DeviceThe study to assess safety and efficacy of Phoenix medical exoskeleton.
NCT Number: NCT03175055
This study will evaluate the Phoenix device for safety and effectiveness at allowing persons with SCI who are non-ambulatory or poorly ambulatory to stand up and walk under a variety of conditions.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
The University of Hong Kong, Hong Kong
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
At rest; Systolic 150 or less Diastolic 90 or less and Heart rate 100 or less Exercise; Systolic 180 or less Diastolic 105 or less and Heart Rate 145 or less
Exclusion criteria
The study to assess safety and efficacy of Phoenix medical exoskeleton.
Time frame: 10 weeks
Time frame: 10 weeks
Time frame: 10 weeks
Time frame: 10 weeks
Testing the ability to ambulate with the device on a variety of surfaces
US Bionics
Industry
Phoenix Exoskeleton Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03702842
Central Nervous System Diseases, Incomplete Spinal Cord Injury
Jacksonville, Florida, United States
View Trial DetailsNCT04855812
Central Nervous System Diseases, Nervous System Diseases
West Orange, New Jersey, United States
View Trial DetailsNCT05945784
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
Pomona, California, United States
View Trial DetailsNCT05022095
Central Nervous System Diseases, Muscle Hypertonia
Nottwil, Canton of Lucerne, Switzerland
View Trial Details